STAGE I BLADDER CANCER AJCC V8
Clinical trials for STAGE I BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine combo shows promise for tough bladder cancer
Disease control Recruiting nowThis early-phase trial tests a new vaccine (IO102-IO103) plus the immunotherapy drug pembrolizumab in 30 adults with a type of bladder cancer that did not respond to or could not tolerate standard BCG therapy. The vaccine aims to train the body's immune cells to recognize and att…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
Nanoparticle therapy targets hard-to-treat bladder cancer in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called PPM for people with non-muscle invasive bladder cancer that has come back or not responded to standard care. PPM uses tiny particles coated with a targeting molecule to deliver a chemotherapy drug directly to cancer cells in the…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 26, 2026 04:09 UTC
-
Immunotherapy may replace chemo for bladder cancer patients
Disease control Recruiting nowThis study compares two treatments for a type of bladder cancer that hasn't spread into the muscle. One group gets standard chemotherapy plus radiation, while the other gets an immunotherapy drug (pembrolizumab) plus radiation. The goal is to see which approach better prevents th…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New combo therapy aims to beat back bladder cancer recurrence
Disease control Recruiting nowThis phase 3 trial tests whether adding the chemotherapy drug gemcitabine to standard BCG immunotherapy can better prevent bladder cancer from coming back. About 330 people with recurrent high-grade non-muscle invasive bladder cancer will receive either BCG alone or BCG plus gemc…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Step up: App-Based exercise program aims to boost activity in bladder cancer patients
Symptom relief Recruiting nowThis study compares a home-based physical activity program delivered through the ExerciseRx app to health education alone in 100 adults with non-muscle invasive bladder cancer. Participants will use a Fitbit to track steps, and the app will set personalized goals and provide enco…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 26, 2026 03:57 UTC
-
Bladder cancer care comes home: new trial tests In-House chemo
Symptom relief Recruiting nowThis study tests whether giving chemotherapy directly into the bladder at home is safe and works as well as doing it in a clinic. About 40 people with early-stage bladder cancer will receive their usual treatment at home. The goal is to see if home treatment is less disruptive an…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC